Secondary findings include a 75.8% reduction in WOMAC pain scores in participants with knee osteoarthritis, a 72% prediabetes-to-normoglycemia reversal rate, and an approximately 20% reduction in LDL cholesterol attributed to glucagon-receptor-driven PCSK9 degradation
Retatrutide is different because it is designed to target three receptors: GLP-1, GIP, and glucagon
Nutrient Requirements during Pregnancy and Lactation
It is an investigational drug in active Phase 3 trials
A supervised plan can help patients understand whether symptoms are expected, whether the dose should be adjusted, whether labs or vital signs should be reviewed, and whether nutrition or bowel support needs to be changed
The constant switching prevents the body from establishing a predictable rhythm and makes side effects harder to manage